Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1387 Views
-
Last post by frodo
-
- 0 Replies
- 1031 Views
-
Last post by frodo
-
- 0 Replies
- 2683 Views
-
Last post by NHE
-
- 0 Replies
- 1333 Views
-
Last post by frodo
-
- 0 Replies
- 1314 Views
-
Last post by frodo
-
- 0 Replies
- 1290 Views
-
Last post by frodo
-
- 0 Replies
- 1683 Views
-
Last post by NHE
-
- 0 Replies
- 561 Views
-
Last post by NHE
-
- 1 Replies
- 3207 Views
-
Last post by Tif